Cyclobenzaprine Hydrochloride Tablet
Product Images NDC 71335-2666

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 71335-2666). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0512aebe 5f3a 4d41 9a41 7c37e001af75 01)

Image (0512aebe 5f3a 4d41 9a41 7c37e001af75 01)
Chemical structure diagram of Cyclobenzaprine Hydrochloride, showing its molecular arrangement with aromatic rings and hydrochloride component.*
FDA Label Image

Label (Lbl713352666)

Label (Lbl713352666)
Cyclobenzaprine Hydrochloride Tablets USP 10 mg label showing quantity of 14 tablets. The label includes storage instructions, dosage information, and repackager Bryant Ranch Prepack, Inc. in Burbank, CA, with manufacturer Graviti Pharmaceuticals Pvt. Ltd. The product is marked Rx only with NDC 71335-2666-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.